1. Home
  2. SQNS vs CTOR Comparison

SQNS vs CTOR Comparison

Compare SQNS & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • CTOR
  • Stock Information
  • Founded
  • SQNS 2003
  • CTOR 2021
  • Country
  • SQNS France
  • CTOR United States
  • Employees
  • SQNS N/A
  • CTOR N/A
  • Industry
  • SQNS Semiconductors
  • CTOR
  • Sector
  • SQNS Technology
  • CTOR
  • Exchange
  • SQNS Nasdaq
  • CTOR NYSE
  • Market Cap
  • SQNS 85.7M
  • CTOR 89.9M
  • IPO Year
  • SQNS 2011
  • CTOR N/A
  • Fundamental
  • Price
  • SQNS $2.63
  • CTOR $1.25
  • Analyst Decision
  • SQNS Strong Buy
  • CTOR Strong Buy
  • Analyst Count
  • SQNS 1
  • CTOR 2
  • Target Price
  • SQNS $7.50
  • CTOR $4.50
  • AVG Volume (30 Days)
  • SQNS 121.8K
  • CTOR 68.9K
  • Earning Date
  • SQNS 02-11-2025
  • CTOR 02-14-2025
  • Dividend Yield
  • SQNS N/A
  • CTOR N/A
  • EPS Growth
  • SQNS N/A
  • CTOR N/A
  • EPS
  • SQNS 2.00
  • CTOR N/A
  • Revenue
  • SQNS $36,762,000.00
  • CTOR N/A
  • Revenue This Year
  • SQNS $10.14
  • CTOR N/A
  • Revenue Next Year
  • SQNS $8.54
  • CTOR N/A
  • P/E Ratio
  • SQNS $1.32
  • CTOR N/A
  • Revenue Growth
  • SQNS 9.36
  • CTOR N/A
  • 52 Week Low
  • SQNS $0.85
  • CTOR $0.85
  • 52 Week High
  • SQNS $7.18
  • CTOR $49.00
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 37.45
  • CTOR N/A
  • Support Level
  • SQNS $2.47
  • CTOR N/A
  • Resistance Level
  • SQNS $3.39
  • CTOR N/A
  • Average True Range (ATR)
  • SQNS 0.22
  • CTOR 0.00
  • MACD
  • SQNS -0.08
  • CTOR 0.00
  • Stochastic Oscillator
  • SQNS 17.39
  • CTOR 0.00

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: